Abstract
The Digital Health Advisory Committee (DHAC) advises the Commissioner of Food and Drugs on issues related to digital health technologies (DHTs), providing relevant expertise and perspective to improve the FDA's understanding of the benefits, risks, and clinical outcomes associated with the use of DHTs.
Key Data
-
Publication Date12 September 2025
-
Primary AuthorU.S. Food and Drug Administration
-
SourceU.S. Food and Drug Administration
-
LanguageEnglish
Click below to visit original source: